This Journal of Addiction Medicine study examines how patients who use nonprescribed stimulants perceive opioid overdose risk and identifies key barriers and facilitators to naloxone access—an essential intervention amid rising fentanyl-related mortality. The authors highlight that polysubstance use, particularly stimulant contamination with opioids, significantly elevates overdose risk, yet many individuals underestimate their personal vulnerability.
Using qualitative methods, the study explores patient perspectives during hospitalization, a critical window for intervention. Findings reveal several persistent barriers to naloxone uptake, including low perceived risk, stigma, limited knowledge of fentanyl exposure, and structural challenges such as access and cost. These barriers mirror broader trends in opioid use disorder (OUD) care, where stigma, inadequate education, and healthcare system gaps continue to impede prevention efforts.
Importantly, the study also identifies facilitators that can improve overdose prevention strategies. Patients expressed greater willingness to accept naloxone when education is personalized, nonjudgmental, and delivered in trusted healthcare settings. Hospital-based interventions—especially those integrating harm reduction education with discharge planning—emerge as high-impact opportunities to expand naloxone distribution and reduce overdose mortality.
This research underscores the urgent need to align clinical practice with patient-centered harm reduction approaches. Enhancing overdose risk awareness, addressing stigma, and embedding naloxone distribution into routine care are critical steps toward reducing opioid-related deaths and improving outcomes across diverse patient populations.
To read the full article: https://journals.lww.com/journaladdictionmedicine/abstract/9900/opioid_overdose_risk_perceptions_and_barriers_and.689.aspx